IJMS SJR and Scopus Metrics: What the Numbers Actually Tell Authors
IJMS looks respectable in Scopus, but the useful interpretation is visibility and indexing strength with real selectivity and reputation trade-offs, not automatic prestige.
Research Scientist, Neuroscience & Cell Biology
Author context
Works across neuroscience and cell biology, with direct expertise in preparing manuscripts for PNAS, Nature Neuroscience, Neuron, eLife, and Nature Communications.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: International Journal of Molecular Sciences has a respectable Scopus profile, but it should be read as a visibility signal more than a prestige signal. Recent metric sources place the journal around an SJR of 1.273, with a CiteScore of 9.0 and recurring Q1 placements in some category views. That confirms real indexing strength, but the submission decision still depends more on selectivity trade-offs and field perception than on the metrics alone.
The core metric picture
Metric | Current read | What it tells you |
|---|---|---|
SJR | 1.273 | Prestige-weighted visibility is real, but not flagship-level |
CiteScore | 9.0 | Four-year citation performance is solid for a high-volume journal |
Quartile | Q1 in several category views | The journal benefits from broad category coverage |
Category nuance | Stronger in some chemistry-facing and molecular-science views | The exact ranking depends on where the journal is grouped |
JCR context | Impact factor 4.9 | Web of Science tells the same visible-but-not-elite story |
The useful reading is that IJMS is a legitimate indexed journal with real citation reach. The metrics do not turn it into a top-prestige molecular-biology venue.
What the metrics actually help with
They help answer the right visibility question:
- is IJMS real and broadly indexed under major systems?
- does the journal have enough citation strength to matter?
- do the Q1 and CiteScore signals explain why authors still choose it?
The answer is yes. The metrics confirm that the journal is visible, widely used, and operationally attractive to many authors.
What the metrics do not answer
They do not tell you:
- whether the journal carries the same prestige as more selective society journals
- how your field reads MDPI and high-volume publishing
- whether the manuscript would gain more from selectivity than speed
- whether the Q1 label means the same thing your coauthors think it means
Those are still the real publishing questions.
Why the profile matters for authors
At this SJR level, IJMS is buying authors:
- broad discoverability
- open-access reach
- strong indexing across major systems
- a journal signal that is easier to defend in Scopus-oriented environments than in prestige-driven lab culture
That is why the journal continues to attract submissions. Its value is access, speed, and visibility, not scarcity.
What should drive the submission decision instead
The better question is whether you want the IJMS trade-off.
That is why the better next reads are:
- Is International Journal of Molecular Sciences a good journal?
- International Journal of Molecular Sciences submission guide
- International Journal of Molecular Sciences submission process
- International Journal of Molecular Sciences acceptance rate
If you want broad indexing, open access, and a fast-moving high-volume journal, the metrics support the choice. If you need stronger field prestige or tighter editorial selectivity, the same metrics are telling you not to overread the Q1 label.
Practical verdict
IJMS has a real Scopus-style profile and is clearly a legitimate, visible publishing option. That makes it a rational choice for some papers and some career contexts.
But the useful takeaway is still trade-off clarity, not prestige theater. If you need a stronger community signal than the journal normally carries, the numbers do not make that problem disappear. A free Manusights scan is the fastest way to pressure-test whether IJMS is actually the right target.
- Is International Journal of Molecular Sciences a good journal?, Manusights.
- International Journal of Molecular Sciences impact factor, Manusights.
Sources
- 1. IJMS journal statistics, MDPI.
- 2. IJMS metrics page, JRank.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.